Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Terminated 4Unknown 2Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 28Carcinoma, Non-Small-Cell Lung 20Triple Negative Breast Neoplasms 9Ovarian Neoplasms 8Lung Neoplasms 8Uterine Cervical Neoplasms 6Adenocarcinoma of Lung 6Neoplasms 5Neoplasm Metastasis 5Esophageal Neoplasms 5Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Recurrence 3Prostatic Neoplasms 3Esophageal Squamous Cell Carcinoma 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Platinum-Refractory Fallopian Tube Carcinoma 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent High Grade Uterine Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Docetaxel 2tislelizumab 1linifanib 1balugrastim 1atezolizumab 1Tiragolumab 1Radiation 1Paclitaxel 1Filgrastim 1Erlotinib Hydrochloride 1Diathermy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Solid Tumors × Paclitaxel × Clear all
NCT01245543 2015-11-02

Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors

Daiichi Sankyo

Phase 1 Withdrawn
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡